<DOC>
	<DOCNO>NCT00145028</DOCNO>
	<brief_summary>To determine Carboplatin 's optimal exposure ( optimal AUCs ) parameter depend .</brief_summary>
	<brief_title>Determination Carboplatin 's Optimal Plasmatic Exposure</brief_title>
	<detailed_description />
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Carcinoma histologically prove must treat Carboplatin , except weekly administer Carboplatin treatment Age &gt; 18 year Neutrophils &gt; 1500/mm3 , bloodplatelets &gt; 100000/mm3 Patient intravenous administration route chemotherapy independent one use blood sample ( Investigators center achieve pharmacokinetic examination ) Wellinformed write consent , sign patient Carboplatin treatment 's contraindication Patient clinically detectable cerebral metastasis Pregnant nursing woman Patient guardianship trusteeship Patient whose venous status n't permit peripheral intravenous administration route 's placing ( Investigators center achieve pharmacokinetic examination )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Neoplasms</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>optimal exposure</keyword>
	<keyword>AUC</keyword>
</DOC>